Please login to the form below

Not currently logged in
Email:
Password:

PPRS

This page shows the latest PPRS news and features for those working in and with pharma, biotech and healthcare.

New Pfizer UK leader as Nordkamp moves into European role

New Pfizer UK leader as Nordkamp moves into European role

newly agreed 2019 Voluntary Scheme for Branded Medicines Pricing and Access (formerly known as the PPRS) and, of course, Brexit.

Latest news

More from news
Approximately 11 fully matching, plus 112 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

  • ABPI names Amgen’s UK head as president ABPI names Amgen’s UK head as president

    of Health to secure the 2014 PPRS.

  • ABPI appoints value and access manager ABPI appoints value and access manager

    initiatives. “These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for

  • Pfizer's Jonathan Emms to be ABPI president Pfizer's Jonathan Emms to be ABPI president

    The UK industry is in the midst of preparing for the introduction of the new version of the Pharmaceutical Pricing Regulatory Scheme ( PPRS) in January, final details of which were published ... Emms' appointment comes after he and his company expressed

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Unique forum will unite NHS and industry to drive innovation

    will be a panellist on a session about‘Negotiating the PPRS – Assessing what comes next’. . ... An overview of the agenda          . Candid and open discussion about access and pricing as the deadline for completing PPRS negotiations

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics